In this study, we found that pemafibrate reduced oxidative stress and the expression levels of inflammatory cytokines and chemokines and that pemafibrate ameliorated iHFC diet-induced MASLD in mice with and without eNOS deficiency. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatotic liver disease.